BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21383689)

  • 1. Methylation of an intronic region regulates miR-199a in testicular tumor malignancy.
    Cheung HH; Davis AJ; Lee TL; Pang AL; Nagrani S; Rennert OM; Chan WY
    Oncogene; 2011 Aug; 30(31):3404-15. PubMed ID: 21383689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer.
    Chen BF; Gu S; Suen YK; Li L; Chan WY
    Epigenetics; 2014 Jan; 9(1):119-28. PubMed ID: 23959088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of regulation and action of microRNA-199a in testicular germ cell tumor and glioblastomas.
    Gu S; Cheung HH; Lee TL; Lu G; Poon WS; Chan WY
    PLoS One; 2013; 8(12):e83980. PubMed ID: 24391856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A miR-199a/miR-214 self-regulatory network via PSMD10, TP53 and DNMT1 in testicular germ cell tumor.
    Chen BF; Suen YK; Gu S; Li L; Chan WY
    Sci Rep; 2014 Sep; 4():6413. PubMed ID: 25231260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
    Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
    Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer.
    Zhang J; Zhu Z; Sheng J; Yu Z; Yao B; Huang K; Zhou L; Qiu Z; Huang C
    Oncotarget; 2017 May; 8(21):34867-34883. PubMed ID: 28432273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL.
    Chijiiwa Y; Moriyama T; Ohuchida K; Nabae T; Ohtsuka T; Miyasaka Y; Fujita H; Maeyama R; Manabe T; Abe A; Mizuuchi Y; Oda Y; Mizumoto K; Nakamura M
    Int J Oncol; 2016 Apr; 48(4):1688-700. PubMed ID: 26892887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
    Liu L; Lu L; Zheng A; Xie J; Xue Q; Wang F; Wang X; Zhou H; Tong X; Li Y; Zhu X; Wu G
    Oncotarget; 2017 Feb; 8(8):13666-13677. PubMed ID: 28099144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.
    Li L; Mou YP; Wang YY; Wang HJ; Mou XZ
    Pathol Res Pract; 2019 Sep; 215(9):152511. PubMed ID: 31255331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation.
    Alexander MS; Kawahara G; Motohashi N; Casar JC; Eisenberg I; Myers JA; Gasperini MJ; Estrella EA; Kho AT; Mitsuhashi S; Shapiro F; Kang PB; Kunkel LM
    Cell Death Differ; 2013 Sep; 20(9):1194-208. PubMed ID: 23764775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of miR-199a-5p target genes in the skin keratinocyte and their expression in cutaneous squamous cell carcinoma.
    Kim BK; Kim I; Yoon SK
    J Dermatol Sci; 2015 Aug; 79(2):137-47. PubMed ID: 26026896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocalyxin-like, targeted by miR-138, promotes colorectal cancer cell proliferation, migration, invasion and EMT.
    Xu Y; Pan ZG; Shu L; Li QJ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8664-8674. PubMed ID: 30575907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
    Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y
    J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.
    Koshizuka K; Hanazawa T; Kikkawa N; Arai T; Okato A; Kurozumi A; Kato M; Katada K; Okamoto Y; Seki N
    Cancer Sci; 2017 Aug; 108(8):1681-1692. PubMed ID: 28612520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum LUCAT1 implicates the pathogenesis of muscle-invasive bladder cancer via targeting miR-199a-5p and miR-199b-5p.
    Zhou Y; Song X; Li X; Li H; Peng Y
    J Mol Histol; 2020 Oct; 51(5):583-591. PubMed ID: 32844284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-199a-3p functions as tumor suppressor by regulating glucose metabolism in testicular germ cell tumors.
    Liu X; Duan H; Zhou S; Liu Z; Wu D; Zhao T; Xu S; Yang L; Li D
    Mol Med Rep; 2016 Sep; 14(3):2311-20. PubMed ID: 27432288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
    Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
    Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.